-
81
-
82
-
83
-
84
-
85by Özevren,Hüseyin, Irtegün,Sevgi, Ekingen,Arzu, Tuncer,Mehmet Cudi, Gökalp-Özkorkmaz,Ebru, Deveci,Engin, Deveci,SenaySubjects: “...VEGF...”
Published 2018
Get full text
-
86
-
87Aflibercept versus Ranibizumab as a Second Line Therapy After Bevacizumab for Diabetic Macular Edemaby Alsaedi NG, Alselaimy RM, Alshamrani AA, AlAjmi M, Khandekar R, Al-Dhibi H, Al-Abdullah AASubjects: “...vegf switch...”
Published 2021
Get full text
article -
88by Callizo J, Ziemssen F, Bertelmann T, Feltgen N, Vögeler J, Koch M, Eter N, Liakopoulos S, Schmitz-Valckenberg S, Spital GSubjects: “...anti-vegf...”
Published 2019
Get full text
article -
89
-
90by Koshak AE, Algandaby MM, Mujallid MI, Abdel-Naim AB, Alhakamy NA, Fahmy UA, Alfarsi A, Badr-Eldin SM, Neamatallah T, Nasrullah MZ, Abdallah HM, Esmat ASubjects: “...vegf...”
Published 2021
Get full text
article -
91by Igor L. Plaksa, Nina D. Mzhavanadze, Roman E. Kalinin, Igor A. Suchkov, Michail U. Bakunov, Vyacheslav T. Krivichin, Sergey A. Matveev, Artur A. Isaev, Roman V. DeevSubjects: “...pl-vegf165...”
Published 2019
Get full text
article -
92by David Blánquez-Martínez, Xando Díaz-Villamarín, Alba Antúnez-Rodríguez, Ana Pozo-Agundo, José Ignacio Muñoz-Ávila, Luis Javier Martínez-González, Cristina Lucía Dávila-FajardoSubjects: “...anti-VEGF...”
Published 2021
Get full text
article -
93
-
94by V. V. Rakhmanov, A. V. Yuryeva, T. S. Varganova, D. I. Sokolov, S. V. Chepanov, K. L. Markova, Yu. S. Astakhov, S. Yu. Astakhov, S. A. SelkovSubjects: “...vegf...”
Published 2021
Get full text
article -
95
-
96
-
97
-
98
-
99
-
100